Psyence Group Inc. (TSE:PSYG) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Psyence Group Inc has completed a strategic restructuring of its non-clinical business, with plans to utilize its global distribution network and expertise in psilocybin to expand its client base and product pipeline. The company aims to ensure the commercial success of its non-clinical assets, while continuing to explore new markets for medical-grade psilocybin.
For further insights into TSE:PSYG stock, check out TipRanks’ Stock Analysis page.

